In humans, serum ALT levels in patients with pre-dialysis chronic kidney disease tend to decrease in proportion to the progression of chronic kidney disease, and serum ALT levels are even lower in patients undergoing hemodialysis [38,39,40,41]. This evidence concerns the gene GPT and chronic kidney disease.